Financial TimesFinancial Times

How science is getting closer to a world without animal testing

By Clive Cookson

14 Aug 2022 · 9 min read

Editor's Note

This Financial Times Big Read dives into the world of animal testing and explains why the practice may begin to filter out as a result of scientific advances.

New technology involving miniature human organs built in a lab is a step towards better treatments and ending a contentious practiceAlex Blyth thought his company had a genius strategy to reinvent cancer treatment. By examining the immunity of the lucky few who had no family history of the disease, Lift Biosciences discovered a potential treatment to destroy tumours for everyone else. Then the cell therapy hit a snag: it did not work when tested on mice.

The bad news came just as Blyth was about to sign a £20mn-plus fundraising round for his Cambridge-based biotech. Investors were shaken by the poor data from the pre-clinical study and, suddenly, he could only raise £5mn, at a lower valuation.

Sign in to informed

  • Curated articles from premium publishers, ad-free
  • Concise Daily Briefs with quick-read summaries
  • Read, listen, save for later, or enjoy offline
  • Enjoy personalized content